Antimicrobial, antimycobacterial and antibiofilm properties of Couroupita guianensis Aubl. fruit extract

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Al Dhabi, Naif Abdullah ^a   Balachandran, Chandrasekar ^b   Raj, Michael Karunai ^b,c   Duraipandiyan, Veeramuthu ^a   Muthukumar, Chinnasamy ^a   Ignacimuthu, Savarimuthu ^b   Khan, Inshad Ali ^d   Rajput, Vikrant Singh ^d  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b LOYOLA COLLEGE   (India)

^c Orchid Chemicals and Pharmaceuticals Ltd   (India)

^d CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Antibiofilm; Antimicrobial; Antimycobacterial; Couroupita guianensis; Indirubin

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMYCOBACTERIAL AGENT; CHLOROFORM; COUROUPITA GUIANENSIS EXTRACT; INDIRUBIN; PLANT EXTRACT; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOFILM; COUROUPITA GUIANENSIS; DRUG EFFICACY; FRUIT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PSEUDOMONAS AERUGINOSA;

ANTI-INFECTIVE AGENTS; BACTERIA; BIOFILMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FRUIT; FUNGI; LECYTHIDACEAE; MYCOBACTERIUM; PLANT EXTRACTS; PSEUDOMONAS AERUGINOSA;

EID: 84870309969     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-242     Document Type: Article

References (41)

1. Lorenzi H. Árvores Brasileiras: Manual de Identificação e Cultivo de Plantas Arbóreas Nativas do Brasil 1998, 352 p. Nova Odessa (SP), Brazil: Editora Plantarum.
2. Mitré M. Couroupita guianensis. IUCN 2012 1998, IUCN Red List of Threatened Species.
3. Sanz-Biset J, Campos-de-la-Cruz J, Epiquién-Rivera MA, Canigueral S. A first survey on the medicinal plants of the Chazuta valley (Peruvian Amazon). J Ethnopharmacol 2009, 122:333-362. 10.1016/j.jep.2008.12.009, 19146943.
4. Kumar CS, Naresh G, Sudheer V, Veldi N, Anurag AE. A Short Review On Therapeutic Uses Of Couroupita Guianensis Aubl. Int Res J Pharm App Sci 2011, 1:105-108.
5. Wong KC, Tie DY. Volatile constituents of Couroupita guianensis Aubl. flowers. J Essent Oil Res 1995, 7:225-227.
6. Rane JB, Vahanwala SJ, Golatkar SG, Ambaye RY, Khadse BG. Chemical examination of the flowers of Couroupita guianensis Aubl. Indian J Pharm Sci 2001, 63:72-73.
7. Bergman J, Lindstrom JO, Tilstam U. The structure and properties of some indolic constituents in Couroupita guianensis Aubl. Tetrahedron 1985, 41:2879-2881.
8. Sen AK, Mahato SB, Dutta NL. Couroupitine A, a new alkaloid from Couroupita guianensis. Tetrahedron Letters 1974, 7:609-610.
9. Row LR, Santry CSPP, Suryananayana PP. Chemical examination of Couroupita guianensis. Curr Sci 1966, 35:146-147.
10. Anjaneyulu ASR, Rao SS. A new ketosteroid from the bark of Couroupita guianensis Aubl. Ind J Chem Sec B: Organic Chemistry 1998, 37:382-386.
11. Eknat AA, Shivchandraji LK. Amirin palmitate isolation from Couroupita guianensis Aubl. leaves. Indian Drugs 2002, 39:213-216.
12. Hoessel R, Leclerc S, Endicott JA, Nobel ME, Lawrie A, Tunnah P, et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol 1999, 1:60-67. 10.1038/9035, 10559866.
13. Han R. Highlight on the studies of anticancer drugs derived from plants in China. Stem Cells 1994, 12:53-63. 10.1002/stem.5530120110, 8142920.
14. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolke RH. Manual of Clinical Microbiology, vol. 6 1995, Washington DC: ASM.
15. Clinical and Laboratory Standards Institute Methods for Antimicrobial Susceptibility Testing of Aerobic Bacteria Approved standard M07-A8 2008, Wayne, PA: National Committee for Clinical Laboratory Standards, 9, Clinical and Laboratory Standards Institute.
16. Wallace RJ, Nash DR, Steele L, Steingrube V. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J Clinical Microbio 1986, 24:976-981.
17. Thenmozhi R, Nithyanand P, Rathna J, Karutha Pandian S. Antibioflim activity of coral-associated bacteria against different clinical M serotypes of Streptococcus pyogenes. FEMS Immunol Med Microbiol 2009, 57:284-294. 10.1111/j.1574-695X.2009.00613.x, 19845763.
18. Regina V, Uma Rajan KM. Phytochemical analysis, antioxidant and antimicrobial studies of fruit rind of Couroupita guianensis (AUBL). Int J Curr Sci 2012, 221:262-267.
19. Umachigi SP, Jayaveera KN, Ashok Kumar CK, Kumar GS. Antimicrobial, Wound Healing and Antioxidant potential of Couroupita guianensis in rats. Pharmacologyonline 2007, 3:269-281.
20. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999, 12:564. 88925, 10515903.
21. Sun D, Courtney HS, Beachey EH. Berberine sulphate blocks adherence of Streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane. Antimicrob Agents Ch 1988, 32:1370-1374.
22. Bacq-Calberg CM, Coyotte J, Hoet P, Nguyem-Disteeche M. Microbiologie 1999, 338. Bruxelles: De Boeck and Larcier.
23. Savafi L, Duran N, Savafi N, Onlem Y, Ocak S. The prevalence and resistance patterns of Pseudomans aeruginosa in intensive care units in a university Hospital. J Med Sci 2005, 35:317.
24. Arvind S, Reg FC, Enzo AP. Identification of antimicrobial components of an ethanolic extract of the Australian medicinal plant. Eremophila duttonii. Phytother Res 2004, 18:615.
25. You J, Xue X, Cao L, Lu X, Wang J, Zhang L, Zhou SV. Inhibition of Vibrio biofilm formation by a marine actinomycete strain A66. Appl Microbiol Biot 2007, 76:1137-1144.
26. Swiatlo E, Champlin FR, Holman SC, Wilson WW, Watt JM. Contribution of choline-binding proteins to cell surface properties of Streptococcus pneumoniae. Infect Immun 2002, 70:412-415. 10.1128/IAI.70.1.412-415.2002, 127640, 11748210.
27. Turi M, Turi E, Koljalg S, Mikelsaar M. Influence of aqueous extracts of medicinal plants on surface hydrophobicity of Escherichia coli strains of different origin. Acta Pathol Microbiol Immunol Scand 1997, 105:956-962.
28. Nostro A, Cannatelli MA, Crisafi G, Musolino AD, Procopio F, Alonzo V. Modifications of hydrophobicity, in vitro adherence and cellular aggregation of Streptococcus mutans by Helichrysum italicum extract. Lett Appl Microbiol 2004, 38:423-427. 10.1111/j.1472-765X.2004.01509.x, 15059215.
29. Prabu GR, Gnanamani A, Sadulla S. Guaijaverin - a plant flavonoid as potential antiplaque agent against Streptococcus mutans. J Appl Microbiol 2006, 101:487-495. 10.1111/j.1365-2672.2006.02912.x, 16882158.
30. Razak FA, Othman RY, Rahim ZH. The effect of Piper beetle and Psidium guajava extracts on the cell-surface hydrophobicity of selected early settlers of dental plaque. J Oral Sci 2006, 48:71-75. 10.2334/josnusd.48.71, 16858135.
31. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004, 2:95-108. 10.1038/nrmicro821, 15040259.
32. Lembke C, Podbielski A, Hidalgo-Grass C, Jonas L, Hanski E, Kreikemeyer B. Characterization of biofilm formationby clinically relevant serotypes of group A Streptococci. Appl Environ Microb 2006, 72:2864-2875.
33. Kannan P, Mohankumar R, Ignacimuthu S, Gabriel paulraj M. Indirubin potentiates ciprofl oxacin activity in the NorA efflux pump of Staphylococcus aureus Scandinavian. J Infect Diseas 2010, 42:500-505.
34. Jakobs S, Merz KH, Vatter S, Eisenbrand G. Molecular targets of indirubins. Int J Clin Pharmacol Ther 2005, 43:592-594.
35. Meijer L, Shearer J, Bettayeb K, Ferandin Y. Diversity of intracellular mecha-nisms underlying the anti-tumor properties of indirubins. Indirubin, the Red Shade of Indigo. Chapter 24 2006, 235-246.
36. Nam S, Buettner R, Turkson J, Kim D, Cheng JQ, Muehlbeyer S, et al. Indirubinanalogs inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci USA 2005, 102:5998-6003. 10.1073/pnas.0409467102, 1087919, 15837920.
37. Leclerc S, Garnier M, Hoessel R, Marko D, Bibb JA, Snyder GL, et al. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?. J Biol Chem 2001, 276:251-260.
38. Perabo FG, Landwehrs G, Frössler C, Schmidt DH, Mueller SC. Antiproliferativeand apoptosis inducing effects of indirubin-30-monoxime in renal cell cancercells. Urol Oncol 2009, 29:815-820.
39. Perabo FG, Frössler C, Landwehrs G, Schmidt DH, von Rücker A, Wirger A, et al. Indirubin-30-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer. Anticancer Res 2006, 26:2129-2135.
40. Marko D, Schätzle S, Friedel A, Genzlinger A, Zankl H, Meijer L, et al. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin analogs in human tumour cells. Br J Cancer 2001, 84:283-289. 10.1054/bjoc.2000.1546, 2363695, 11161389.
41. Zhen Y, Sørensen V, Jin Y, Suo Z, Wiedłocha A. Indirubin-30-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK. Oncogene 2007, 26:6372-6385. 10.1038/sj.onc.1210473, 17533378.